I read with interest the recent contribution by Yang et al. [1] , in Endocrine. The same content was also reported by Mahajan et al. [2] , by including markers of insulin resistance. Both studies adopted a cross-sectional design, and causal relationship should be explored by longitudinal study. As a common finding, obesity was strongly related to serum C-reactive protein (CRP) compared with other metabolic components. In contrast, hyperglycemia and elevated blood pressure were significant, but relatively weak association with CRP.
I have some concerns on study by Yang et al. [1] . First, they used sex as adjusting variable for the total group of metabolic syndrome (MetS) and for each metabolic component. The odds ratio (95 % confidence interval) of the highest tertile of CRP for MetS is 5.04 (3.41-7.45) in men and 9.92 (6.64-14.82) in women. As there is a sex difference of odds ratio, stratified analysis by sex is recommended in every analysis.
Second Third, diabetes mellitus is a risk factor for atherosclerotic cardiovascular disease, including coronary heart disease and ischemic stroke. In addition, there is a report that elevated CRP was independently associated with risk of impaired fasting glucose and/or impaired glucose tolerance [3] . This means that subclinical association between CRP and several metabolic components should also be evaluated. The odds ratios (95 % confidence intervals) of the highest group of CRP for hyperglycemia are 2.10 (1.56-2.84) and 1.27 (101-1.59) by Yang et al. and Mahajan et al., respectively. The outcome concerning the relationship between CRP and hyperglycemia should be evaluated in other ethnic groups to keep generalizability of the study.
